Cart
sales@molnova.com
Methyl 3-hydroxy-4,5-dimethoxybenzoate
CAS No. 83011-43-2
Methyl 3-hydroxy-4,5-dimethoxybenzoate( —— )
Catalog No. M31073 CAS No. 83011-43-2
Methyl 3-hydroxy-4,5-dimethoxybenzoate shows fairly active for oxidation resistance in the presence of H2O2.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 52 | In Stock |
|
| 5MG | 85 | In Stock |
|
| 10MG | 140 | In Stock |
|
| 25MG | 236 | In Stock |
|
| 50MG | 342 | In Stock |
|
| 100MG | 505 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1079 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMethyl 3-hydroxy-4,5-dimethoxybenzoate
-
NoteResearch use only, not for human use.
-
Brief DescriptionMethyl 3-hydroxy-4,5-dimethoxybenzoate shows fairly active for oxidation resistance in the presence of H2O2.
-
DescriptionMethyl 3-hydroxy-4,5-dimethoxybenzoate shows fairly active for oxidation resistance in the presence of H2O2. It shows obvious antimicrobial activities, the minimum inhibitory concentration of it is 5 mg/ml against Staphylococcus aureus and Rhizopus, and 10 mg/ml against E. coli.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number83011-43-2
-
Formula Weight212.2
-
Molecular FormulaC10H12O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
H-Phe(4-Cl)-D-Cys-β-...
PRL 3195 is a somatostatin receptor antagonist with Kis of 6, 17, 66, 1000 and 1000 nM for human somatostatin receptors (sst5, sst2, sst3, sst1 and sst4, respectively).
-
Platycodin A
Platycodin A is monoacetylated saponin compound isolated fromhe roots of Platycodon grandiflorum A. DC..
-
Soyasaponin Aa
Soyasaponin Aa and soyasaponin Ab dose-dependently markedly inhibit adipocyte differentiation and expression of various adipogenic marker genes, through the downregulation of the adipogenesis-related transcription factors PPARγ and C/EBPα± in 3T3-L1 adipocytes.
